Citation Impact
Citing Papers
Improved precision on the radius of the nearby super-Earth 55 Cnc e
2012 StandoutNobel
A hot Uranus transiting the nearby M dwarf GJ 3470
2012 StandoutNobel
TheSpitzersearch for the transits of HARPS low-mass planets
2017 StandoutNobel
TheSpitzersearch for the transits of HARPS low-mass planets
2010 StandoutNobel
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
Enzyme therapy for Gaucher disease: the first 5 years
1998
Glycosphingolipidoses: Beyond the enzymatic defect
2004
Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III
1999
Presenilins are essential for regulating neurotransmitter release
2009 StandoutNatureNobel
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells
2003
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors
2006
Immunologic properties of human fetal mesenchymal stem cells
2004
Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy
2006
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
2009 Standout
Glucocerebrosidase is shaking up the synucleinopathies
2014
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Marine natural products
1990 Standout
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
A map of the large day–night temperature gradient of a super-Earth exoplanet
2016 StandoutNatureNobel
Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons
2000
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
1994
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
2004
Parkinson's disease
2009 Standout
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Pharmacologic chaperoning as a strategy to treat Gaucher disease
2007
Endurance exercise performance: the physiology of champions
2007 Standout
Genetic medicines: treatment strategies for hereditary disorders
2006
Lysosomal storage disorders
2005
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Demonstration of Direct Glycosylation of Nondegradable Glucosylceramide Analogs in Cultured Cells
1995
Alglucerase
1992
How were new medicines discovered?
2011 Standout
The Human Gene Map for Performance and Health-Related Fitness Phenotypes
2006
Biomedical applications of collagen
2001 Standout
Neuropathology provides clues to the pathophysiology of Gaucher disease
2004
Gaucher's Disease: A Review
1996
Direct observation of the nanoscale dynamics of membrane lipids in a living cell
2008 StandoutNatureNobel
Evaluation of Human Skin Reconstituted from Composite Grafts of Cultured Keratinocytes and Human Acellular Dermis Transplanted to Athymic Mice
1996
Allogeneic bone marrow transplantation for lysosomal storage diseases
1995
Non-motor features of Parkinson disease
2017 Standout
1-Deoxynojirimycin Derivatives from the Marine Sponge Lendenfeldia chondrodes
2006
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
2010
Biodegradation, biodistribution and toxicity of chitosan
2009 Standout
Hematopoietic and nonhematopoietic potentials of Hoechstlow/side population cells isolated from adult rat kidney
2004 StandoutNobel
Bone marrow–derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases
1999
Natural products to drugs: natural product derived compounds in clinical trials
2005
Structural and Mutational Analysis of Human Ad37 and Canine Adenovirus 2 Fiber Heads in Complex with the D1 Domain of Coxsackie and Adenovirus Receptor
2006
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Shape effects of filaments versus spherical particles in flow and drug delivery
2007 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice
1997
Oncolytic adenoviruses – selective retargeting to tumor cells
2005
Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice
1999
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Lysosomal storage diseases
1995
X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease
2003
Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1
2003
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.
1995 StandoutNobel
Solution-phase total synthesis of the hydrophilic natural product argifin using 3,4,5-tris(octadecyloxy)benzyl tag
2011 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats
2001 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Variability in the super-Earth 55 Cnc e
2015 StandoutNobel
THE B7 FAMILY REVISITED
2005 Standout
Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey
2002
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types
2002 StandoutNobel
Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development inCaenorhabditis elegans
2008 StandoutNobel
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
2014 StandoutNobel
Clinical spectrum of infantile free sialic acid storage disease
1999
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
2007
Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.
1993
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
2004
Kinetics of Central Nervous System Microglial and Macrophage Engraftment: Analysis Using a Transgenic Bone Marrow Transplantation Model
1997
Science and technology for water purification in the coming decades
2008 StandoutNature
Exploring single-molecule dynamics with fluorescence nanoscopy
2009 StandoutNobel
Catastrophic evaporation of rocky planets
2013
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
1991
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Advances in Male Contraception
2008
Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation
1994
TRANSIT CONFIRMATION AND IMPROVED STELLAR AND PLANET PARAMETERS FOR THE SUPER-EARTH HD 97658 b AND ITS HOST STAR
2014 StandoutNobel
Works of Anders Erikson being referenced
Lysosomal free sialic acid storage disorders with different phenotypic presentations--infantile-form sialic acid storage disease and Salla disease--represent allelic disorders on 6q14-15.
1995
Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts
1991
5 Neuronopathic forms of Gaucher's disease
1997
Enzyme Replacement Therapy of Infantile Gaucher Disease
1993
Clinical and Biochemical Outcome of Marrow Transplantation for Gaucher Disease of the Norrbottnian Type
1990
Norrbottnian Type of Gaucher Disease – Clinical, Biochemical and Molecular Biology Aspects: Successful Treatment with Bone Marrow Transplantation
1991
Remaining problems in the management of patients with Gaucher disease
2001
Comet-like tail-formation of exospheres of hot rocky exoplanets: Possible implications for CoRoT-7b
2010
The role of the iminosugar N‐butyldeoxynojirimycin (miglustat) in the management of type I (non‐neuronopathic) Gaucher disease: A position statement
2003
Glycerol kinase deficiency: follow‐up during 20 years, genetics, biochemistry and prognosis
2004
Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.
1990
TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASE
1995
Gaucher disease‐Norrbottnian type (III)
1986
Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
1982
There Are Two Different Species B Adenovirus Receptors: sBAR, Common to Species B1 and B2 Adenoviruses, and sB2AR, Exclusively Used by Species B2 Adenoviruses
2002
LONG-TERM FOLLOW-UP OF THE FIRST SUCCESSFUL BONE MARROW TRANSPLANTATION IN GAUCHER DISEASE
1988
Management of neuronopathic Gaucher disease: A European consensus
2001
Neuropathology of the Norrbottnian type of Gaucher disease
1984